BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Cardiol. Apr 26, 2026; 18(4): 118431
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.118431
Unwanted silent crosstalk: Troponinemia and surgeons
Ayman El-Menyar
Ayman El-Menyar, Department of Surgery, Hamad Medical Corporation, Doha 3050, Qatar
Ayman El-Menyar, Clinical Medicine, Weill Cornell Medicine, Doha 24144, Qatar
Author contributions: El-Menyar A conceptualization, methodology, writing, and review of the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Ayman El-Menyar, Department of Surgery, Hamad Medical Corporation, Al-Rayyan Street, Doha 3050, Qatar. aymanco65@yahoo.com
Received: January 4, 2026
Revised: January 8, 2026
Accepted: January 28, 2026
Published online: April 26, 2026
Processing time: 103 Days and 14.8 Hours
Core Tip

Core Tip: The Major non-cardiac surgery is associated with a significant risk of perioperative mortality. This adverse outcome relies mainly on the occurrence of myocardial injury in the perioperative settings. Myocardial injury after non-cardiac surgery remains widely unrecognized, partly because there is no universal consensus on its definition and diagnostic criteria. However, a working diagnosis can be established based on an elevated post-operative cardiac troponin level within 30 days of surgery after excluding other non-ischemic causes, regardless of whether the patient has symptoms or electrocardiogram findings. There is growing consensus for proactive surveillance to mitigate the burden of perioperative cardiovascular complications.